How are Pharmakogenetik Medicheck and Müdigkeit related?

The link between pharmacogenetics (Medicheck) and fatigue is indirect and evidence‑weak. Pharmacogenetic tests analyze gene variants affecting drug metabolism (e.g., CYP2D6, CYP2C19, CYP3A4). Fatigue can be a side effect of medications whose breakdown is genetically slowed – for instance, certain antidepressants or beta‑blockers. However, the provided context contains no specific study showing a direct connection between a pharmacogenetic profile and fatigue without concurrent medication. The often‑cited MTHFR gene is considered clinically irrelevant for routine testing by the ACMG. Evidence is therefore rated as 'unclear'. Supplements should not be taken based solely on a pharmacogenetic test. For persistent fatigue, a medical workup (blood count, thyroid, iron, vitamin B12, vitamin D) is more appropriate than genetic interpretation.